DOT1L
dot1L: A Gene with Critical Roles in Gene Expression and Disease
Description
dot1L (disruptor of telomeric silencing 1-like) is a histone methyltransferase enzyme that plays a pivotal role in gene expression regulation and chromatin dynamics. It catalyzes the methylation of histone H3 at lysine residue 79 (H3K79), a modification associated with gene activation and transcription elongation.
dot1L is essential for the establishment and maintenance of heterochromatin, a condensed and inactive form of chromatin found at the centromeres of chromosomes and other genomic regions. It also plays a crucial role in telomere maintenance and genomic stability.
Associated Diseases
Mutations in dot1L have been implicated in several human diseases, including:
- Malignant myeloid disorders: dot1L mutations are commonly found in myelodysplastic syndromes (MDS), a group of blood cancers characterized by abnormal blood cell development.
- Acute myeloid leukemia (AML): dot1L alterations have also been associated with AML, a more aggressive type of blood cancer.
- Neurological disorders: Mutations in dot1L have been linked to neurological disorders such as intellectual disability and autism spectrum disorder.
- Developmental disorders: Disruptions in dot1L function can lead to developmental disorders, including Wolf-Hirschhorn syndrome and microcephaly.
Did you Know ?
Approximately 20% of MDS patients have mutations in the dot1L gene, making it one of the most frequently mutated genes in this disease.
